Wednesday, April 19, 2017
Equity Trader Alert #2017 - 84
(UPDATED) Information Regarding Reverse Merger and Business Combination between Dipexium Pharmaceuticals, Inc. (DPRX) and PLx Pharma Inc.
The reverse merger and business combination of Dipexium Pharmaceuticals, Inc. and PLx Pharma Inc. became effective today, Wednesday, April 19, 2017. Dipexium Pharmaceuticals, Inc. (DPRX) will undergo a one-for-eight (1-8) reverse stock split, a change of name, a change of symbol, and a new CUSIP number. The details are as follows:
For information regarding this announcement, contact Nasdaq Corporate Data Operations at +1 877 308 0523.
If you would like to register as a market maker in PLXP, contact Nasdaq Trading Services at +1 212 231 5100.
Nasdaq (Nasdaq: NDAQ) is a leading global provider of trading, clearing, exchange technology, listing, information and public company services. Through its diverse portfolio of solutions, Nasdaq enables customers to plan, optimize and execute their business vision with confidence, using proven technologies that provide transparency and insight for navigating today's global capital markets. As the creator of the world's first electronic stock market, its technology powers more than 89 marketplaces in 50 countries, and 1 in 10 of the world's securities transactions. Nasdaq is home to 3,800 total listings with a market value of $11 trillion. To learn more, visit: business.nasdaq.com.